# SAPHRIS
> **NDA022117** · New Drug Application · Sponsor: ABBVIE · Approved 2009-08-13
## Drug
- **FDA Application Number:** NDA022117
- **Application type:** New Drug Application
- **Brand name:** SAPHRIS
- **Generic name:** ASENAPINE MALEATE
- **Active ingredients:** ASENAPINE MALEATE
- **Dosage form:** TABLET
- **Route:** SUBLINGUAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2009-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022117)
---
*AI Analytics · CC0 1.0*